Researchers have developed a stem cell-based model of the human intestine that may transform how new IBD treatments are ...
VivoSim’s NAMkind™ Intestinal Model combined with AI prediction tools yields high-accuracy results. SAN DIEGO, April 28, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: V ...
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”) announced today that its NAMkind™ platform for intestinal efficacy prediction was recognized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results